Phase I clinical study of oral olaparib in pediatric patients with refractory solid tumors: study protocol

Overview of attention for article published in BMC Pediatrics, January 2019

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)

Mentioned by

twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 27 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 6,080 followers.

RT @SarcomaAlliance: This article describes an open clinical trial in Japan for pediatric solid tumors including sarcomas that haven't resp…

02 Feb 2019

Reply Repost Favourite

RT @SarcomaAlliance: This article describes an open clinical trial in Japan for pediatric solid tumors including sarcomas that haven't resp…

31 Jan 2019

Reply Repost Favourite

This article describes an open clinical trial in Japan for pediatric solid tumors including sarcomas that haven't responded to treatment or that have recurred, using the PARP inhibitor olaparib. https://t.co/1BUlON9cgY https://t.co/1BUlON9cgY

31 Jan 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.